Evaluation of some biochemical changes in diabetic patients

Clinica Chimica Acta

Volumn 346, Issue 2, 2004, Pages 161-170

  Abou Seif, Mosaad A ^a   Youssef, Abd Allah ^b  

^a Mansoura University   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

AGEs; Amylase and nitric oxide; Antioxidants; AOPP; ceruloplasmin; Cp; Diabetes mellitus; IDDM; insulin dependent diabetes mellitus; Lipid profiles; malondialdehyde; MDA; NIDDM; non insulin dependent diabetes mellitus; Trace elements

Indexed keywords

AMYLASE; ANTIOXIDANT; CALCIUM; CATALASE; CERULOPLASMIN; COPPER; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; NITRIC OXIDE; PANCREAS ENZYME; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRACE ELEMENT; TRIACYLGLYCEROL; ZINC;

ADULT; AMYLASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CERULOPLASMIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COPPER BLOOD LEVEL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EVALUATION; FEMALE; GLYCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; TRACE METAL BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; ZINC BLOOD LEVEL;

AGED; AMYLASES; CASE-CONTROL STUDIES; CATALASE; CERULOPLASMIN; DIABETES MELLITUS; FEMALE; GLUTATHIONE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LIPIDS; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; PHENYLALANINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRACE ELEMENTS;

FELIS CATUS;

EID: 3142534320     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.03.030     Document Type: Article

References (51)

1. Kannel W.B., McGee D. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 59:1979;8-12
2. Brown I.R., McBain A.M., Chalmers J., Campbell I.W., Brown E.R., Lewis M.J. Sex difference in the relationship of calcium and magnesium excretion to glycaemic control in type-1 diabetes mellitus. Clin. Chim. Acta. 283:1999;119-128
3. Cunningham J.J., Fu A., Mearkle P.L., Brown R.G. Hyperzincurea in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high dose zinc supplementation. Metabolism. 43(12):1994;1558-1562
4. Isbir T., Tamer L., Taylor A., Isbir M. Zinc, copper and magnesium in insulin-dependent diabetes. Diabetes Res. 26(1):1994;41-45
5. Gillery P. Advanced glycation end products (AGEs), free radicals and diabetes. J. Soc. Biol. 195(4):2001;387-390
6. Kalousova M., Skrha J., Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol. Res. 51:2002;597-604
7. Opara E.C. Oxidative stress, micronutrients, diabetes mellitus and its complications. J. R. Soc. Health. 122(1):2002;28-34
8. Abou-Seif M.A.M., Youssef H. Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients. Clin. Chem. Lab. Med. 39(7):2001;618-623
9. Paterson J., Pettegrew A., Dominiczak M.H., Small M. Screening for hyperlipidaemia in diabetes mellitus. Relation to glycemic control. Ann. Clin. Biochem. 28:1991;254-258
10. Lopes-Virella M.F., Virella G. Lipoproteins and immune response in the vascular wall and their contribution to atherosclerosis in diabetes. Metabolism. 4(5):1992;11-15
11. Velazquez E., Winocour P.H., Kesteven P., Alberti K.G., Laker M.F. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet. Med. 8:1991;752-758
12. Moncado S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142
13. Hardt P.D., Killinger A., Nalop J., Schnell-Kretschmer H., Zekorn T., Klor H.U. Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Pancreatology. 2(1):2002;30-33
14. Vantyghem M.C., Haye S., Balduyck M., Hober C., Degand P.M., Lefebvre J. Changes in serum amylase, lipase and leukocyte elastase during diabetic ketoacidosis and poorly controlled diabetes. Acta Diabetol. 36(1):1999;39-44
15. Friedewald W.J., Levy R.J., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502
16. Beutler E. A manual of biochemical methods. Beutler E. Red Cell Metabolism. 3rd ed. 1984;72-136 Grune & Stratton, Philadelphia
17. Erdincler D.S., Seven A., Inci F., Beger T., Canden G. Lipid peroxidation and antioxidant status in experimental animals: effects of aging and hypercholesterolemic diet. Clin. Chim. Acta. 265:1997;77-84
18. Hortellano S., Dewez B., Genaro A.N. Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology. 21:1995;776-786
19. Kakker P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 21:1984;130-132
20. Bock P.P., Kramer R., Pavelka M. A simple assay for catalase determination. Cell Biol. Monogr. 7:1980;44-74
21. Henry R.J., Chiamori N., Jacobs S.L., Segalove M. Estimation of ceruloplasmin concentrations in biological fluids. Proc. Soc. Exp. Biol. Med. 104:1960;620-625
22. Henry R.J., Chiamori N. Determination of α-amylase activity in plasma and urine of pancreatic diseases. Clin. Chem. 6:1960;434-441
23. Wootton I.D.P. Determination of serum proteins. Wootton I.D.P. Microanalysis in Medical Biochemistry. 5th ed. 1974;98-157 Churchill, London
24. Tallman D.L., Taylor C.G. Potential interactions of zinc in the neuroendocrine-endocrine disturbances of diabetes mellitus type 2. Can. J. Physiol. Pharmacol. 77:1999;919-933
25. Lin J. The association between copper ions and peroxidative reaction in diabetic cataract. Nippon Ganka Gakkai Zasshi. 100(9):1996;672-679
26. Hunt J.V., Wolff S.P. Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radic. Res. Commun. 12-13:1991;115-123
27. Sajithlal G.B., Chithra P., Chandrakasan G. The role of metal-catalyzed oxidation in the formation of advanced glycation end products: an in vitro study on collagen. Free Radic. Biol. Med. 25(3):1998;265-269
28. Tian H., Han L., Ren Y., Li X., Liang J. Lipoprotein(a) level and lipids in type 2 diabetic patients and their normoglycemic first-degree relatives in type 2 diabetic patients. Diabetes Res. Clin. Pract. 59(1):2003;63-69
29. Regnström J., Nilsson J., Tornvall P., Landou C., Hamsten A. Susceptibility of low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 339:1992;1183-1186
30. Nishigake I., Hagihara M., Tsunekawa H., Maseki M., Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem. Med. 25:1981;373-378
31. Heinecke J.W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74:1984;1890-1894
32. de Graaf, Hendricks J.C.M., Demacker P.N.M., Stalenhoef A.F.H. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects: normalization after clofibrate treatment. Arterioscler. Thromb. 13:1993;712-719
33. Lavy A., Brook G.J., Dankner G., Amotz A.M., Aviram M. Enhanced in vitro oxidation of plasma lipoprotein derived from hypercholesterolemic patients. Metabolism. 40:1991;794-799
34. Alcock N.W. Trace elements. Kahn A.L., Pesce A.J. Clinical Chemistry, Theory, Analysis and Correlation. 1996;746-759 Mosby-Year Book, St. Louis
35. Sharpe P., Liuk W., Yue K., McMaster D., Catherwood M., McGinty A., et al. Glucose induced oxidative stress in vascular contactile cells. Diabetes. 47:1998;801-809
36. Aria K., Lizuka S., Tada Y., Oikawa K., Taniguch N. Increase in the glucosylated form of erythrocyte Cu, Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity. Biochem. Biophys. Acta. 924:1989;292-296
37. Zbronska H., Grzeszczak W., Jendryczko A., Zbronski R., Kuzniewicz R. Activity of superoxide dismutase in erythrocytes and leukocytes and levels of zinc and copper in blood of patients with diabetes. Effects of diabetic treatment on examined parameters. Pol. Arch. Med. Wew. 94(3):1995;228-234
38. McCord J.M. Jr., Keele B.B., Fridovich I. An enzyme based theory of obligate anaerobiosis: the physiological function of superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 34(8):1971;487-490
39. Yoshida K., Hirokawa J., Tagami S., Kawakami Y., Urate Y., Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabeteologia. 38(2):1995;201-210
40. Miyakojima H. Aceruloplasminemia Rinsho Shinkeigaku. 40(12):2000;1290- 1292
41. Hatanake Y., Okano T., Oda K., Yamamoto K., Yoshida K. Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern. Med. 42(7):2003;599-604
42. Rakonczay Z., Jarmay K., Kaszaki J., Mandi Y., Duda E., Hegyi P., et al. NF-kappaB activation is detrimental in arginine-induced acute pancreatitis. Free Radic. Biol. Med. 34(6):2003;696-709
43. Yu J.H., Lim J.W., Namkung W., Kim H., Kim K.H. Suppression of cerulin-induced cytokine expression by antioxidants in pancreatic acinar cells. Lab. Invest. 28(10):2002;1359-1368
44. Bierhaus A., Hofmann M.A., Ziegler R., Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. The AGE concept. Cardiovasc. Res. 37:1998;586-600
45. Fields M., Lewis C.G. Impaired endocrine and exocrine pancreatic functions in copper-deficient rats: the effect of gender. J. Am. Coll. Nutr. 16(4):1997;346-351
46. Orchard T.J. Magnesium and type 2 diabetes mellitus. Arch. Intern. Med. 159:1999;2119-2120
47. Um S.H., Know Y.D., Kim C.D., Lee H.S., Jeen Y.T., Chun H.J., et al. The role of nitric oxide in experimental cerulin induced pancreatitis. J. Korean Med. Sci. 18(4):2003;520-526
48. Kedziora-Kornatowska K.Z., Luciak M., Blaszczyk J., Pawlak W. Effect of aminoguanidine on the generation of superoxide anion and nitric oxide by peripheral blood granulocytes of rats with streptoztocin-induced diabetes. Clin. Chim. Acta. 278:1998;45-53
49. Fasterman U. Identification of the NO synthase isoforms expressed in human neutrophils, granulocytes, megakaryocytes and platelets. Thromb. Haemost. 77:1997;163-167
50. Nakai K., Fujii S., Yamamoto A., Igarashi J., Kuboto Y., Kosaka H. Effects of high glucose on NO synthesis in human keratinocyte cell line (HaCaT). I. Dermatol. Sci. 31(3):2003;211-218
51. Morel D.W., Chisolm G.M. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J. Lipid Res. 30:1989;1827-1834